INTRODUCTION
Smoking during pregnancy is very well acknowledged to increase the risk of vascular complications in otherwise low-risk women (Quinton et al., 2008) . Smoking also increases the risk of preterm birth, placental abruption and placenta praevia in uncomplicated pregnancies. Prenatal exposure to smoking in pregnant women increases the risk of delivering babies with Low Birth-weight (LBW), intrauterine growth restriction (IUGR) (Huang et al., 2017) and causes perinatal morbidity and mortality (Salafia and Shiverick, 1999; Quinton et al., 2008) . The placenta is a highly specialized organ that supports the exchange of nutrients and waste products between maternal and fetal circulatory system. In addition, placenta secretes a large number of hormones and peptides, which help in regulation of feto-placental circulation, maternal health and fetal outcome (Gude et al., 2004) . In normal pregnancy, the placental vasculature is dilated to its maximum capacity to permit optimal exchange between mother and the fetus. Towards the end of pregnancy, stimulation of local autacoids enhances vasoconstriction as well as vasodilation leading to normal delivery of the baby. Long acting autacoids such as endothelins have been implicated for mediating sustained vasoconstriction (To, 2012; Carter and Myatt, 1995) . Among these, endothelins are recently discovered endothelium derived peptides, which show potent contractile effects in vascular and visceral smooth muscles. Out of the three different isoforms (ET-1, ET-2 and ET-3), Endothelin-1 (ET-1) is the most potent vasoconstrictor compound (Masaki and Yanagisawa, 1992) . It is a peptide having 21 amino acids, which was first isolated and sequenced from the supernatant of cultured porcine aortic endothelial cells (Yanagisawa et al., 1988) . The effects of ET-1 have been extensively studied in the normal placental tissue as well as maternal serum (Gude et al. 1991; Myatt et al., 1992) . The levels of ET-1 have been reported to be elevated in maternal serum in patients with Pregnancy Induced Hypertension (PIH) and Pre-eclampsia (Sudo et al., 1993) . It is also reported that ET-1 is localized in endothelial cells (Marinoni et al., 1995) of chorionic villi, amniotic epithelium (Hemsen et al., 1991) and villous trophoblast (Marinoni et al., 1995; Malassine et al., 1993 ) of human placenta. But the localization of ET-1 in the placental tissue of smoking mother is very sparsely studied. According to Economides and Braithwaite (1994) nicotine in any form increases the level of carbon monoxide in blood leading to inactivation of fetal and maternal hemoglobin and thus resulting in hypoxia. Asmussen (1980) and Jauniaux and Burton (1992) reported morphological and ultrastructural changes in placenta of smoking mother but very few literature is available on localization of ET-1 in smoker's placenta. Therefore, the present study was undertaken to examine the distribution pattern and localization of ET-1 in tobacco smokers in comparison to nonsmokers with the help of immunohistochemical technique.
MATERIALS AND METHODS

Sample Collection
Placentas (n=50) were collected immediately after normal singleton vaginal delivery from healthy full-term mothers who had been previously enrolled for this study visiting the Antenatal Clinic (ANC) and admitted in Labor Room of Dept. of Obstetrics & Gynecology, MKCG Medical College and Hospital, Berhampur, Odisha, India. The participants were classified into two groups (n=25 each) based on the tobacco exposure before and during pregnancy. Non-smokers (Control Group) were those who reported no history of smoking either by herself or any of her close relatives. Active Smokers were those mothers who directly smoked 15 cigarettes or 30 'bidis' or more per day for at least 2 years before and during pregnancy.
Subjects were matched for maternal age, parity and gestational age. Those with history of any debilitating diseases were excluded from our study. For immuno-histochemical studies, the placental tissues were collected from the fetal side of placenta after fixed by perfusion technique in Trump's fixative (pH 7.2-7.4). All placentas were examined for conventional gross and light microscopic features as per the guidelines of the College of American Pathologists (Driscoll and Langston, 1991) . The study was approved by the local Scientific Ethical Committee and samples were collected according to the "Ethical guidelines for biomedical research on human participants" issued be Indian Council of Medical Research (ICMR).
Tissue Processing
5mm placental tissue sections were immersion fixed in 10% buffered formalin within 10 min after delivery. The fixed placental tissues were processed for routine paraffin embedding. Five micron (5m) thick sections were cut and mounted on clean glass slides.
Immunohistochemistry
These slides were kept in the oven at 60°C for 20 minutes. Tissue sections were then de-paraffinized and rehydrated. The endogenous peroxidase activity was quenched by immersing the de-paraffinized sections in 3% H 2 O 2 in Methanol for 30 minutes. Sections were rinsed in Phosphate Buffered Saline (PBS) of pH-7.2 and then exposed to microwaves for 10 minutes in Antigen Retrieval Solution (8.2 mM sodium citrate, 1.8mM Citric acid-pH-6.0, containing 0.01% Triton X-100). After subsequent washing with PBS, the sections were exposed to blocking serum for 45 minutes to block the nonspecific binding. The sections were then incubated in a humidified chamber (37 o C) with primary monoclonal anti-Endothelin-1 antibody (Oncogene Research Products, Boston, MA, USA) at a dilution of 1:250 (tested over a range of 1:100 to 1:1000) diluted in PBS containing 1% BSA and 0.2% Tween-20 for overnight at 4-8°C. Negative controls were achieved by omitting primary antibody while rest of the procedure remained the same.
The sections were then washed in PBS containing 0.2% Tween-20 and immuno-staining was achieved using an Avidin-Biotin Complex (ABC) developer kit (Vectastain Elite ABC Kit, Vector Laboratories; Burlingame, CA, USA). The complex was detected using 3, 3'-diaminobenzidine (DAB) as a substrate. Sections were counterstained with Mayer's hematoxylin for 2 minutes, washed and mounted (Hsu et al., 1981) . In each experiment, an additional serial section was stained with anti- Human CD-31 mAb (pre-diluted concentration of 200g/ml; Sigma, St. Louis, MO, USA) that served as a positive control and permitted a comparison between the distribution of ET-1 and that of the endothelial cell marker, CD-31. Olympus upright microscope fitted with digital camera (Olympus, E-520) was used for capturing microphotographs.
RESULTS
Endothelial cells (EC) were identified and confirmed by immunostaining with endothelial cell marker, anti-human CD-31 mAb. Fine granular and dark brown deposits of ET-1 (achieved due to DAB substrate & chromogen reaction) were observed in the ECs lining the capillaries of tertiary villi of full-term control placenta (Fig.1) . Immunostaining was limited to ECs only and was not discernible in syncytiotrophoblasts or other cells of placenta. The distribution pattern of ET-1 was similar to the immunostaining of endothelial cell marker, anti-human CD-31 (Fig.2) . This confirms that the expression and localization of ET-1 is only in the endothelial cells of placental villi. Fig.1 
Fig1. Endothelial cells (EC) in capillaries of chorionic villi of placenta characterized by ET-1 (arrow) positivity. (Non-smoker, ET-1 mAb, Mayer's Haematoxylin, 100x)
Fig2. CD-31 immunoreactivity (double arrow) in EC of placental capillaries is localized to similar regions showing ET-1 positivity in
. (Non-smoker, CD-31 mAb, 100x)
Negative control (Fig. 3 a & b) shows absence of immunostaining due to omission of primary antibody from the normal Avidin-Biotin complex (ABC) procedure indicating thereby that the staining is specific for ET-1 as well as CD-31.
Fig3(a&b). Negative control showing absence of immunoreactivity in endothelial cells of placenta due to elimination of primary antibodies-(a) CD31 mAb and (b) ET-1 mAb. (100x)
The distribution pattern of ET-1 immunoreactivity was also investigated in the placenta of active smokers and observed to be more intense as compared to non-smokers. In addition to the ET-1 immunostaining in the ECs lining the capillaries, focal immunostaining was observed in ECs lining small to medium sized blood vessels (Fig.4) . When compared with the distribution pattern of CD-31 mAb in the serial sections of smoker's placenta, the distribution of ET-1 immunostaining followed similar pattern as in case of CD-31 ( Fig.5 ). All the other cells constituting the placental villi, such as, syncytiotrophoblasts, cytotrophoblasts, connective tissues, stromal tissues and vascular smooth muscle cells were observed to be negative for ET-1 immunoreactivity in the study group. ) have also observed that ET-1 increases the myometrial smooth muscle tone, which implies that this peptide may initiate the normal parturition, as well as pre-term labor in mothers exposed to tobacco.
Fig4. Endothelin-1(arrow) expressing endothelial cells (EC) in placental villi with intense staining. (Active Smoker, ET-1, 100x)
Fig5. CD-31 (double arrow) immunostaining in EC of placental villi showing similar distribution pattern as ET-
The present study revealed that there was no difference in the distribution pattern of ET-1 and CD-31 immunoreactivity and the immunostaining pattern of ET-1 was similar to that of endothelial cell markers, CD-31 in the placental tissues of both the study groups, viz. active smoker and non smoker group, suggesting that cells lining the venules and capillaries of placental villi can synthesize ET-1 or ET-1 like material. The ET-1 immunoreactivity, however was absent in the negative control slides of both the study groups, which proves that there was no non-specific binding of ET-1 to the placental tissues. It is thus, concluded that the ET-1 peptide is present only at those sites where endothelial cells are located along the lumen of fetal capillaries of placental villi, irrespective of control or study group.
In case of smokers and non-smokers placenta immunostaining of ET-1 was not continuous around the lumen of the endothelial cells. Expression of Endothelin-1 m-RNA in porcine and human tissue has also been described to be focal (Nunez et al. 1990 ). Similarly, Wilkes et al. (1993) observed focal immunostaining in the medium to large arteries and veins but noted that staining reaction was stronger in the capillaries of the placental villi. In our study, we also observed such strong immunoreactivity attributable to placental villi of active group as compared to non-smokers.
According to Wilkes et al. (1993) endothelin causes prolonged vasoconstriction in placenta which is mediated by binding of endothelin to specific high affinity receptor sites. Onda et al. (1990) are of opinion that endothelin-3 gene for endothelin is expressed by placenta. Thus it is presumed that expression of endothelin in blood vessels of placenta of both the groups may be a regulated process depending upon the requirement of fetus and nicotine may also have an influence in endothelin secretion. Though we cannot comment on the quantity of ET-1 in the placental villi, the present study (which is a qualitative study) has revealed that the ET-1 immunoreactivity was present in endothelial cells lining the capillaries of the placental villi of smokers as well as non-smokers. It was further noted that endothelial lining of the blood capillaries of placental villi of active smokers displayed stronger immunoreactivity in comparison to non-smokers group. Therefore, it is possible that tobacco smoke or nicotine (as it the main constituent alkaloid of tobacco) might promote the synthesis of ET-1 in placental capillaries where nutrients and gas exchange take place between mother and the fetus. Thus it could be concluded that nicotine or there may be some other vasoactive peptides or hormones present in the placenta of tobacco consuming mothers, which might be responsible for bringing out the morphological and physiological changes in the placenta (Asmussen, 1980 ; Jauniaux and Burton, 1992).
CONCLUSION
The expression of ET-1 was observed along the endothelial lining of fetal blood vessels of smokers as well as non-smokers placenta. The immunostaining of the endothelial cells of capillaries of smokers and non-smokers placenta was not continuous. The ET-1 immunoreactivity in placenta of active smokers was consistently observed to be more intense as compared to non-smokers. Thus, it may be concluded that tobacco (nicotine) or some other vasoactive peptides or hormones present in the placenta of tobacco consuming mothers, might be responsible for bringing out the morphological and physiological changes in the placenta.
